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Aims: Centella asiatica has been used to treat kidney diseases in Chinese traditional medicine. Asiaticoside (an ex-
traction of C. asiatica) exerts a variety of pharmacological effects including immunomodulatory and anti-
inﬂammatory functions. However, the mechanism of asiaticoside in the treatment of renal diseases remains
largely unknown. This study investigated the molecular mechanism of asiaticoside in treating adriamycin-
induced nephropathy of rats.
Mainmethods: Sixty-two SDmale rats were randomly divided into normal control group (n = 12) and nephrop-
athy group (n = 50). Except for the normal control group, rats were injected with adriamycin (6 mg/kg) via the
tail vein to induce nephropathy. Adriamycin induced nephropathic ratswere divided into untreated group, pred-
nisone group (25 mg/kg), and asiaticoside groups with various dosages (8, 16 and 32 mg/kg). Samples of urine
and serum, tissue of kidney were collected for analysis after treatments for four weeks. Morphological changes
were evaluated under light microscope and electron microscope. Synaptopodin, desmin, nephrin and podocin
mRNA and protein were determined by RT-PCR and Western blotting.
Key ﬁndings: Compared to the untreated nephropathy group, asiaticoside treatment mitigated histological dam-
ages, decreased 24-hour urine protein excretion and total cholesterol, increased serum albumin. Asiaticoside
treatment increased the mRNA and protein levels of synaptopodin, nephrin and podocin in a dose-dependent
manner. Furthermore, asiaticoside treatment decreased the mRNA and protein levels of desmin.
Signiﬁcance: Asiaticoside can mitigate adriamycin-induced nephropathy in rats, which is associated with the
increase in synaptopodin, nephrin and podocin gene expression, and the decrease in desmin gene expression.© 2013 The Authors. Published by Elsevier Inc.Open access under CC BY license.Introduction
Proteinuria is one of themost common features of renal disease and
is a consequence of problemswith the glomerular ﬁltration barrier. The
glomerular ﬁltration barrier is composed of capillary endothelial cells,
glomerular basementmembrane (GBM) and the slit diaphragm located
between the foot processes of podocytes. Since the fenestrae of endo-
thelial cells have large diameters, ﬁltration of the protein by this portion
of the barrier is limited. The GBMhas a surface richwith anionic charges
and functions as a charge barrier, and is composedofﬁbers arranged in a
ﬁne sieve-like network. Podocytes are located outside of the GBM and
are divided structurally and functionally into three portions: cell body,
major processes, and foot processes. Microtubules maintain and alter
the morphology of podocyte foot process by arranging an actin-based86 29 88118691.
.Open access under CC BY license.cytoskeletal system. Adjacent podocyte foot processes interdigitate,
with interstices bridged by a slit diaphragm (SD). The SD ﬁltration
membrane barrier is the most important portion of the large ﬁltration
barrier (Ishizuka et al., 2007). Podocytes are an end-stage differentiated
cell, lacking regenerative capacity following abscission (Kerjaschki,
2001). They comprise the last barrier against the protein loss from the
body. Once podocytes are injured, proteinuria develops. The special
structure of podocytesmainly depends on the expression of cytoskeletal
system components and a number of speciﬁc proteins. These speciﬁc
protein molecules and proteins of the slit diaphragm are important
portions of the podocyte barrier, regulating normal renal function.
The adriamycin-induced nephropathy model was reported in the
early 1980s and has been widely used in the ﬁeld of kidney disease.
Adriamycin is a quinone-containing anthracycline antibiotic and can
be reduced to a semiquinone radical by metabolism in the kidney. The
latter reacts with oxygen to produce reactive oxygen, inducing lipid
peroxidation in the glomerular epithelial cells and destruction of the
structure and function of the ﬁltration membrane and ultimately
proteinuria (Oka et al., 2008). An acute adriamycin-induced nephropa-
thy model is induced by a single tail vein injection of 5–7.5 mg/kg
adriamycin. This model similar to human minimal change nephrotic
Table 1
Real-time PCR primer sequences.
Genes Forward primer (5′-3′) Reverse primer (5′-3′)
Synaptopodin CCACAGAGGCACATAATG GGATACAGAGTAGAATAAGAGG
Desmin TCCTACACCTGCGAGATTG GCGATGTTGTCCTGATAGC
Nephrin TTCTGCTGCTCTCCAATG ACTTCTGCTGTGCTAACC
Podocin GGTGATTGCTGCCGAAGG CTGTGGACAAGGACTGAAGAG
353Z. Wang et al. / Life Sciences 93 (2013) 352–358syndrome has been well characterized as an experimental model for
nephrotic syndrome.
Centella asiatica is a member of the umbelliferae group of plants,
and may reduce swelling, stimulate circulation, and promote diuresis
(Qi andWang, 2010). C. asiatica has been used to reduce urinary protein
excretion in the treatment of kidney diseases for thousands of years in
China. The chemical components of C. asiatica include triterpenoid sapo-
nins, triterpene acids, polyacetylene alkenes and volatile oils (Chen and
Sun, 2006). Asiaticoside is widely used clinically for its pharmacological
properties, such as immunomodulatory, anti-inﬂammatory, and anti-
viral properties, as well as promotion of wound healing (Yang, 2008).
However, the exactmechanism of action of asiaticoside in the treatment
of renal diseases remains largely unknown. The present study was
designed to examine therapeutic roles of asiaticoside in adriamycin-
induced nephropathy in rats. Speciﬁcally, effects of asiaticoside on ex-
pression of synaptopodin, desmin, nephrin and podocin were examined.
Materials and methods
Animals
Sixty-two male healthy SPF-grade SD rats (150 ± 20 g) were pro-
vided by the Experimental Animal Center of the School of Medicine,
Xi'an Jiaotong University. Rats were housed under conditions of con-
stant temperature (21 ± 2 °C) and humidity (60%) and exposed to a
12-h dark-light cycle. All rats were fed on a standard pellet diet and
water was freely available.
Experimental design
Rats were randomly divided into a normal control group (Group A,
n = 12) and a nephropathy model group (n = 50). The nephropathy
model was prepared as described previously (Ren et al., 2010). Rats
were injected with adriamycin (6 mg/kg, single dose) via the tail vein
to induce nephropathy. The control group rats were injected with sa-
line. Nephropathywas conﬁrmed after threeweeks bymassive protein-
uria, hypoalbuminemia, hyperlipidemia as well as by foot process
effacement illustrated by electron microscopy (at the end of seventh
week). Forty nephropathy rats were randomly divided into untreated
nephropathy model group (Group B), asiaticoside groups (Groups C,
D, and E, n = 8, respectively) and a positive control group (Group F,
n = 8). Prednisone was used as a positive control (Gipson et al., 2009).
From the 4thweek on, Groups A andBwere administered saline; Groups
C, D, and E were administered 8 mg/kg, 16 mg/kg, and 32 mg/kg
asiaticoside (Zhang et al., 2007), respectively; Group F was administered
25 mg/kg prednisone. All drugs and saline were administered by gavage
once a day for 4 weeks.
At the end of the 3 and 7 weeks after the ﬁrst adriamycin injection,
24 h urine samples were collected by metabolic cages; blood was
collected from the abdominal aorta, and serumwas prepared via centri-
fugation and stored at−20 °C. At the end of the 7 weeks, all rats were
euthanized. Parts of fresh kidney tissueswere removed and ﬁxed in 10%
formaldehyde for routine histological examination; whereas another
part of the kidney tissues was ﬁxed in 2% glutaraldehyde for transmis-
sion electron microscopy examination. The remaining kidney tissues
were kept in liquid nitrogen for protein and mRNA measurements. All
animal procedures were conducted in accordance with the China
AnimalWelfare Legislation andwere approved by the Ethics Committee
on the Care and Use of Laboratory Animals in Xi'an Jiaotong University
(Shaanxi, China).
Biochemical analyses
Twenty four-hour urine protein excretion was measured by pyro-
gallol red-molybdate method (DiaSys Diagnostic Systems Co., Ltd,
Shanghai). The levels of albumin (ALB), serum triglyceride (TG), totalcholesterol (TC), urea nitrogen (BUN), and creatinine (Cr)were detected
by Automatic Analyzer (7600-020, Hitachi, Tokyo, Japan).
Histological examination
The ﬁxed tissue specimens were dehydrated in graded alcohol solu-
tions, cleared in toluene, and embedded in parafﬁn. Sections (3 μm)
were stained with periodic acid-Schiff stain (PAS). For the electron
microscopic analysis, 1 × 1 × 1 mm3 fragments of the renal tissues
were ﬁxed overnight in cold glutaraldehyde (2%) in 0.1 M sodium
cacodylate buffer for 2 h in 4 °C. After dehydration in graded ethanol,
the pellets were embedded in Spurr. Ultra-thin sections were observed
with the electron microscope (H600A, Hitachi, Tokyo, Japan).
Real-time-polymerase chain reaction (PCR)
Total RNA was puriﬁed from fresh rat kidney cortex tissue (50–
100 mg) on ice with RNAfast1000 (Pioneer, China). The purity of
total RNA was checked with a spectrophotometer and the wave-
length absorption ratio (260/280 nm) was between 1.7 and 2.0 in
all preparations. Reverse transcription of total RNA (0.1–5 μg) to
cDNA was carried out using RevertAid First Strand cDNA Synthesis
Kits (MBI, Lithuania) in 20 μL volume reaction at 44 °C for 1 h by
using Mastercycler personal PCR machine (Eppendorf AG, Hamburg,
Germany). Speciﬁc primers were designed using Beacon Designer
4.0 software and synthesized with Sunbiotech (Beijing Sunbiotech
CO., Ltd, China). Real-time PCR was performed with Maxima SYBR
Green/ROX qPCR Master Mix (2×) (MBI, Lithuania) in the IQ5.0 sys-
tem (BioRad, USA). The system automatically monitors the binding
of a ﬂuorescent dye SYBR® Green to double-stranded DNA during
each cycle of PCR ampliﬁcation. PCR was performed under the fol-
lowing conditions: Heating 50 °C for 2 min, followed by 95 °C for
10 min and 40 PCR cycles with 94 °C for 15 s, 60 °C for 30 s, 72 °C
for 30 s. The relative amount of mRNA was calculated using the com-
parative Ct (ΔΔCt) equation. The β-actin genewas used as a reference
for normalizing data. Derived normalized values are the mean of
three runs. The sequences of the rat and human primers (Beijing
Sanbo Yuanzhi Biotechnology, Ltd) are listed in Table 1.
Western blotting
Kidney tissuehomogenates or cellswere lysedbyRIPA (radioimmuno-
precipitation assay) lysis buffer (Pioneer, China), which enables the
extraction of cytoplasmic, membrane and nuclear proteins. Samples
containing 100 μg of protein were subjected to 10% sodium dodecyl
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and then
transferred to a PVDF membrane. Nonspeciﬁc binding was blocked
with 5% non-fat dry milk in 0.1% Tween-20/TBS (TBST) for 1 h at
room temperature. Following washing with TBST, the blots were
incubated overnight at 4 °C with the primary antibody: synaptopodin,
1:500 (Proteintech, USA), desmin, 1:1000 (Proteintech, USA), podocin,
1:200 (Proteintech, USA), nephrin, 1:200 (Abcam, USA), and β-actin,
1:2000 (Santa Cruz Biotechnology, USA). The membranes were incu-
bated for 1 h at room temperature with the corresponding HRP-
conjugated secondary antibodies (synaptopodin, desmin, podocin, and
nephrin were goat anti-rabbit IgG(H + L); β-actin was goat anti-
mouse IgG(H + L), Pierce, USA). Signals were visualized using a GE
Table 2
Twenty four hours urinary protein excretion at the end of 3rd week.
Groups n 24 h urinary protein excretion (mg/24 h)
A 12 37.99 ± 14.99
B–F 40 109.82 ± 25.67#
(A)Normal control group. (B)Nephropathymodel group. (C)Asiaticoside (8 mg/kg) group.
(D) Asiaticoside (16 mg/kg) group. (E) Asiaticoside (32 mg/kg) group. (F) Prednisone
(25 mg/kg) group. Values were expressed as mean ± S.D. #, P b 0.05 vs. Group A.
Table 3
Twenty four hours urinary protein excretion at the end of 7th week.
Groups n 24 h urinary protein excretion (mg/24 h)
A 12 42.32 ± 10.15
B 8 162.77 ± 27.51#
C 8 140.08 ± 15.23▲
D 8 109.77 ± 19.64▲
E 8 107.90 ± 8.94▲
F 8 97.55 ± 12.82▲
(A)Normal control group. (B)Nephropathymodel group. (C)Asiaticoside (8 mg/kg) group.
(D) Asiaticoside (16 mg/kg) group. (E) Asiaticoside (32 mg/kg) group. (F) Prednisone
(25 mg/kg) group. Values were expressed as mean ± S.D. #, P b 0.05 vs. Group A; ▲,
P b 0.05 vs. Group B.
354 Z. Wang et al. / Life Sciences 93 (2013) 352–358ImageQuant LAS4000mini, quantiﬁed using densitometry with the Gel
Doc XR System (Bio-Rad Laboratories, Hercules, CA, USA), and analyzed
using Quantity One Protein Analysis Software (Bio-Rad Laboratories,
Hercules, CA, USA).
Reagents
Asiaticoside with purity over 95% was purchased from Guangxi
Changzhou Natural Products Development Co., Ltd, China (Batch num-
ber: 110124). Asiaticosidewas dissolved in 0.5% sodium carboxymethyl
cellulose. Adriamycinwas provided by Zhejiang Haizheng Pharmaceuti-
cal Co., Ltd., China. Prednisone acetate was obtained from Xi'an Lijun
Pharmaceutical Co., Ltd., China.
Statistical analyses
SPSS version 16.0 for Windows was used for all analyses. All values
are expressed as mean ± SD. Statistical signiﬁcance between experi-
mental groups was determined by a t test or analysis of variance
(ANOVA). P values b 0.05 were considered statistically signiﬁcant.
Results
Determination of 24 h urinary protein excretion
As indicated above, forty nephropathy rats were randomly divided
into untreated nephropathy model group, asiaticoside groups with
variable dosages (8 mg/kg, 16 mg/kg and 32 mg/kg) and a positive con-
trol group. As shown in Tables 2 and 3, after 3 weeks of adriamycin
injection, 24 h urinary protein excretion increased in rats with Group
B compared with rats in Group A (P b 0.05), suggesting that the
nephropathy model was successfully established. At the end of theTable 4
Biochemical parameters at the end of 3rd week after the ﬁrst adriamycin injection.
Groups n ALB (g/L) BUN (mmol/L)
A 12 31.69 ± 1.21 8.31 ± 0.65
B–F 40 27.59 ± 2.77# 10.78 ± 2.12
(A) Normal control group. (B) Nephropathy model group. (C) Asiaticoside (8 mg/kg) group
(25 mg/kg) group. Values were expressed as mean ± S.D. #, P b 0.05 vs. Group A.experiment, urinary protein excretion was signiﬁcantly reduced in the
asiaticoside-treated groups (Group C, D, and E) and the positive control
group (Group F) (P b 0.05).Biochemical analyses
Serum ALB in Group B decreased three weeks following adriamycin
injection, while serums TC and TG were signiﬁcantly higher than those
in Group A (P b 0.05) (Table 4). At the end of the seventh week, ALB in
Groups C, D, and E were higher than that in Group B. In addition, as
shown in Table 5, asiaticoside treatment reduced TC and TG compared
with Group B (P b 0.05).Histological ﬁndings
As shown in Fig. 1A, under the light microscopic examination, no
evident pathological changes were found in the kidney of Group a.
Whereas in Group b, the glomerular changes consisted of proliferation
of glomerularmesangial cells, increase ofmesangialmatrix and glomer-
ular capillary lumen narrowing; the tubular changeswere characterized
by inﬂammatory cell inﬁltration in the renal interstitium. In Groups d, e
and f, these pathological damages (indicated with arrows in Fig. 1A)
were lighter than those of Group b, especially in Group e.
As shown in Fig. 1B, under the electron microscope, integrity of
podocyte structure, clear foot process, and intact basal structure were
observed in the kidney of Group a. In Group b, foot processes were
broadened, fused, evenly disappeared, along with podocyte loss and
cell number reduction. There was no apparent improvement in patho-
logical damages in Group c; whereas in Groups d, e and f, the severity
of pathological damages (indicated with arrows in Fig. 1B) was clearly
ameliorated, especially identiﬁed by the recovery of the structure and
the number of podocyte foot process. These improvementsweremostly
observed in Group e.mRNA levels
As shown in Fig. 2, mRNA levels of synaptopodin, nephrin and
podocin in adriamycin-induced nephropathy model were signiﬁcantly
decreased, whereas the mRNA expression of desmin was increased
when compared with the normal control group (P b 0.05). In contrast,
asiaticoside treatment increased the mRNA levels of synaptopodin,
nephrin and podocin, and decreased the levels of desmin mRNA in a
dose-dependent manner (P b 0.05).Protein levels
As shown in Fig. 3, protein levels of synaptopodin, nephrin and
podocin were signiﬁcantly decreased, whereas desmin protein was
increased in adriamycin-induced nephropathy model compared with
the control group (P b 0.05). In contrast, asiaticoside treatment in-
creased the protein levels of synaptopodin, nephrin and podocin, and
decreased the levels of desmin protein in a dose-dependent manner
(P b 0.05).Cr (μmol/L) TC (mmol/L) TG (mmol/L)
49.65 ± 3.22 1.54 ± 0.44 1.35 ± 1.15
57.44 ± 5.93 11.41 ± 0.96# 9.24 ± 5.4#
. (D) Asiaticoside (16 mg/kg) group. (E) Asiaticoside (32 mg/kg) group. (F) Prednisone
Table 5
Biochemical parameters at the end of 7th week after the ﬁrst adriamycin injection.
Groups n ALB (g/L) BUN (mmol/L) Cr (μmol/L) TC (mmol/L) TG (mmol/L)
A 12 30.24 ± 1.38 7.89 ± 1.57 53.80 ± 5.62 1.79 ± 0.34 1.52 ± 0.52
B 8 20.85 ± 2.08# 10.52 ± 3.62 57.10 ± 8.13 12.89 ±1.59# 10.76 ± 2.05#
C 8 22.93 ± 4.75 11.78 ± 2.56 57.48 ± 5.44 10.47 ± 2.30 8.72 ± 3.84
D 8 25.93 ± 3.18▲ 11.48 ± 3.77 55.84 ± 5.20 9.83 ± 1.96 5.36 ± 2.13▲
E 8 26.13 ± 1.49▲ 9.05 ± 1.82 54.85 ± 4.07 8.79 ± 1.73▲ 5.07 ± 2.72▲
F 8 30.55 ± 6.3▲ 9.67 ± 5.99 57.08 ± 8.58 8.48 ± 1.41▲ 18.84 ± 7.13
(A) Normal control group. (B) Nephropathy model group. (C) Asiaticoside (8 mg/kg) groups. (D) Asiaticoside (16 mg/kg) group. (E) Asiaticoside (32 mg/kg) group. (F) Prednisone
(25 mg/kg) group. Values were expressed as mean ± S.D. #, P b 0.05 vs. Group A;▲, P b 0.05 vs. Group B.
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Podocytes are located at the outer layer of GBM and possess foot
processes that interdigitate and create small pores that are spanned
by SD; podocytes and SDs are the last component of the glomerular
ﬁltration barrier. SD has been observed via electron microscopy to
resemble a zipper-like structure spanning the space between foot
processes (Rodewald and Karnovsky, 1974). The specialized structureFig. 1.Morphological changes of kidney after asiaticoside treatment demonstrated by light
the kidneys in different groups. Panels represent images of tissues from animals with differe
(d) Asiaticoside (16 mg/kg). (e) Asiaticoside (32 mg/kg). (f) Prednisone (25 mg/kg). Arrows iof a podocyte regulates its overall functions, which can be summarized
as follows: (1) molecular protein ﬁltration barrier; (2) protein ﬁltration
charge barrier; (3) resisting the hydrostatic pressure of the glomeruli;
(4) maintaining the spatial structure of the glomerular capillary loops;
(5) synthesizing the ingredients necessary for maintaining the integrity
of GBM; and (6) synthesizing and secreting vascular endothelial growth
factor to maintain the functional integrity of the glomerular endothelial
cells (Shankland, 2006).microscopy (PAS × 400) (A) and transmission electron microscopy (×10,000) (B) of
nt treatments: (a) Normal control. (b) Nephropathy model. (c) Asiaticoside (8 mg/kg).
ndicate the structural changes (A) and foot processes (B) of the glomerulus.
Fig. 2. Effects of asiaticoside onmRNA levels of synaptopodin, nephrin, desmin and podocin. Real-time PCRwas performed using total RNA from kidney tissues. (A) Normal control group.
(B) Nephropathymodel group. (C) Asiaticoside (8 mg/kg) group. (D) Asiaticoside (16 mg/kg) group. (E) Asiaticoside (32 mg/kg) group. (F) Prednisone (25 mg/kg) group. The results of
synaptopodin, nephrin, desmin and podocin levels were expressed as relative to the corresponding β-actin. Values were expressed as mean ± S.D. (n = 6). *, P b 0.05 vs. Group B.
356 Z. Wang et al. / Life Sciences 93 (2013) 352–358Synaptopodin and desmin are cytoskeletal proteins. During kidney
development, synaptopodin is not expressed in the predecessor cells of
podocytes (Sun andWang, 2004). Therefore, synaptopodin is considered
as an important marker of mature podocytes. Compared to normal kid-
ney tissue, synaptopodin expression progressively declines in minimal
change disorder (MCD) and mesangial proliferative glomerulonephritis
(MSPGN). Furthermore, synaptopodin in tissue from kidneys with focal
segmental glomerulosclerosis (FSGS) decreases markedly (Srivastava
et al., 2001). The expression of synaptopodin is increased in patients
with idiopathic collapsing glomerulopathy and HIV-associated nephrop-
athy (Yang et al., 2002). Desmin is an intermediate ﬁlament protein of
the cytoskeleton and is secreted by podocytes during injury (Floege
et al., 1992). Desmin expression and podocyte injury are signiﬁcantly
correlated (Kerjaschki and Neale, 1996).
Nephrin and podocin are protein components of the ﬁltration slit
diaphragm. Nephrin expression is found only in the pores between
glomerular podocytes (Miner, 1999). Thus, it is believed that
nephrin is one of the main components of SD, a component of the
renal ﬁltration barrier. A gene mutation in NPHS1 can lead to the loss
of nephrin expression, causing destruction of SD and signiﬁcant protein-
uria (Aoyama et al., 2006; Li et al., 2004). Reduced mRNA and protein
expression of nephrin occurs earlier than ultrastructural changes in
podocytes. Therefore, nephrin can be used as an early important bio-
marker for acute glomerular podocyte injury (Bo et al., 2003;
Kucukardali et al., 2008). As a scaffolding protein, podocin plays animportant role in maintaining the structure and function of SD. In vitro
and in vivo studies have conﬁrmed that podocin plays a scaffolding
role in lipid rafts of foot process membrane in podocytes, which are
critical to the structure and function of SD (Browman et al., 2007;
Philippe et al., 2008). Podocin mutant mice have early proteinuria and
progressive renal failure, with pathological manifestations including
severe mesangial sclerosis, wide fusion of foot processes, and SD disap-
pearance (Philippe et al., 2008). Reduced expression of podocin is an ini-
tiating factor in the development of proteinuria (Liu et al., 2012). In
summary, cytoskeletal proteins and SD proteins affect the structure
and the function of podocytes.
Prevention and treatment of podocyte injury and amelioration of
proteinuria are important interventional strategies for nephropathy.
In the present study, histological changes (proliferation of glomerular
mesangial cells, increased mesangial matrix, glomerular capillary
lumen narrowing, and inﬂammatory cell inﬁltration in the renal
interstitium) were shown under the light microscopic examination.
Images under transmission electron microscope further demonstrated
foot process effacement in the nephropathy group, indicating the
success of model establishment. After the treatment with asiaticoside,
the histological damages were mitigated, especially in the high dose
of asiaticoside group. Furthermore, asiaticoside was able to reduce
urine protein excretion in the adriamycin-induced nephropathy rats.
Elevated serum albumin and lower total cholesterol content were also
observed in asiaticoside treatment groups.
Fig. 3. Effects of asiaticoside on protein levels of synaptopodin, nephrin, desmin and podocin.Western blotting was performed using total protein from kidney tissues. (A) Normal control
group. (B)Nephropathymodel group. (C)Asiaticoside (8 mg/kg) groups. (D)Asiaticoside (16 mg/kg) group. (E)Asiaticoside (32 mg/kg) group. (F) Prednisone (25 mg/kg) groups. The results
of synaptopodin, nephrin, desmin and podocin levels were expressed as relative to the corresponding β-actin. Values were expressed as mean ± S.D. (n = 6). *, P b 0.05 vs. Group B.
357Z. Wang et al. / Life Sciences 93 (2013) 352–358In addition, asiaticoside increased the expression of synaptopodin
and decreased desmin expression in rats with adriamycin-induced
nephropathy, suggesting that asiaticoside restored the expression of
cytoskeletal proteins in damaged podocytes. For SD proteins, asiaticoside
increased the expression of nephrin and podocin in a dose-dependent
manner. Taken together, our study suggests that asiaticoside protection
against renal disease might be accomplished through altering foot
process cytoskeleton and SD protein component expression, resulting
in phenotypic changes in podocytes and subsequentally restoring nor-
mal morphology and repair of the glomerular ﬁltration barrier.Asiaticoside is the main chemical extracted from C. asiatica. Our
study provides insights into the mechanisms involved in C. asiatica
treatment for kidney disease, and highlights new potential thera-
peutic targets for nephropathy. Although we have demonstrated
that the alternative expressions of synaptopodin, nephrin, podocin
and desmin genes are associated with the podocyte injury, their
roles in the occurrence and development of proteinuria remain
unclear. Additional mechanisms underlying the therapeutic effect
of asiaticoside on podocytes in kidney disease require further
studies.
358 Z. Wang et al. / Life Sciences 93 (2013) 352–358Conclusion
In the present study, asiaticosidemitigated the histological damages,
decreased 24-hour urine protein excretion, TC, and increasedALB in rats
of adriamycin-induced nephropathy. These protective effects were as-
sociated with the increase in synaptopodin, nephrin and podocin gene
expression, and the decrease in desmin gene expression.
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